Vesna Bačić Vrca

685 total citations
27 papers, 464 citations indexed

About

Vesna Bačić Vrca is a scholar working on Geriatrics and Gerontology, Toxicology and Hematology. According to data from OpenAlex, Vesna Bačić Vrca has authored 27 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Geriatrics and Gerontology, 5 papers in Toxicology and 5 papers in Hematology. Recurrent topics in Vesna Bačić Vrca's work include Pharmaceutical Practices and Patient Outcomes (10 papers), Pharmacovigilance and Adverse Drug Reactions (5 papers) and Antibiotic Use and Resistance (4 papers). Vesna Bačić Vrca is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (10 papers), Pharmacovigilance and Adverse Drug Reactions (5 papers) and Antibiotic Use and Resistance (4 papers). Vesna Bačić Vrca collaborates with scholars based in Croatia, Slovenia and Canada. Vesna Bačić Vrca's co-authors include María Ximena Rojas, Bruno Baršić, Juan David Rueda, Jason Nickerson, Ljiljana Mayer, Ivana Čepelak, Srečko Marušić, Željko Romić, Igor Rudež and Bojan Biočina and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cochrane Database of Systematic Reviews and Clinica Chimica Acta.

In The Last Decade

Vesna Bačić Vrca

25 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vesna Bačić Vrca Croatia 10 175 116 87 71 61 27 464
Lenneke Haas Netherlands 12 217 1.2× 60 0.5× 94 1.1× 32 0.5× 58 1.0× 36 514
Daniel Carl United States 13 261 1.5× 65 0.6× 184 2.1× 31 0.4× 34 0.6× 25 743
Lori D Wazny Canada 14 32 0.2× 93 0.8× 115 1.3× 36 0.5× 66 1.1× 39 602
Steven P. Dunn United States 15 67 0.4× 83 0.7× 151 1.7× 78 1.1× 99 1.6× 36 789
Apichard Sukonthasarn Thailand 11 159 0.9× 22 0.2× 143 1.6× 86 1.2× 39 0.6× 47 641
Donald Yin United States 17 131 0.7× 187 1.6× 196 2.3× 280 3.9× 20 0.3× 30 895
Peter Pickkers Netherlands 6 618 3.5× 132 1.1× 170 2.0× 39 0.5× 17 0.3× 12 1.0k
Noa Markovits Israel 11 41 0.2× 51 0.4× 98 1.1× 17 0.2× 18 0.3× 21 370
Kullaya Takkavatakarn Thailand 15 59 0.3× 64 0.6× 105 1.2× 27 0.4× 9 0.1× 51 571
Ulrich Jaschinski Germany 13 375 2.1× 78 0.7× 95 1.1× 27 0.4× 16 0.3× 20 688

Countries citing papers authored by Vesna Bačić Vrca

Since Specialization
Citations

This map shows the geographic impact of Vesna Bačić Vrca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vesna Bačić Vrca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vesna Bačić Vrca more than expected).

Fields of papers citing papers by Vesna Bačić Vrca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vesna Bačić Vrca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vesna Bačić Vrca. The network helps show where Vesna Bačić Vrca may publish in the future.

Co-authorship network of co-authors of Vesna Bačić Vrca

This figure shows the co-authorship network connecting the top 25 collaborators of Vesna Bačić Vrca. A scholar is included among the top collaborators of Vesna Bačić Vrca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vesna Bačić Vrca. Vesna Bačić Vrca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kuharić, Maja, et al.. (2024). Perspectives of primary care physicians on academic detailing for antimicrobial stewardship: feasibility and impact assessment. Journal of International Medical Research. 52(1). 3639283170–3639283170. 1 indexed citations
3.
Kifer, Domagoj, Maja Kuharić, Marina Payerl-Pal, et al.. (2024). Evaluating academic detailing as an antibiotic stewardship intervention in primary healthcare settings in Croatia. BMC Primary Care. 25(1). 426–426. 1 indexed citations
4.
Vrca, Vesna Bačić, et al.. (2024). Assessment of Potential Drug–Drug Interactions of Psycholeptics and Antidepressants in Outpatient Settings. SHILAP Revista de lepidopterología. 12(6). 174–174. 1 indexed citations
5.
Vrca, Vesna Bačić, et al.. (2023). Antimicrobial Stewardship and Dose Adjustment of Restricted Antimicrobial Drugs in Hospital Setting. SHILAP Revista de lepidopterología. 11(2). 68–68. 1 indexed citations
6.
Vrca, Vesna Bačić, et al.. (2021). Antimicrobial drugs involved in potential drug-drug-interactions in cardiosurgical patients. 76(1). 6–11. 1 indexed citations
7.
Vrca, Vesna Bačić, et al.. (2021). Potential clinically significant drug-drug interactions in prescribed pharmacotherapy in an outpatient setting.. PubMed. 76(8). 390–395. 6 indexed citations
8.
Butković, Ana, et al.. (2021). Association between reported medication adherence and health-related quality of life in adult patients with haemophilia. International Journal of Clinical Pharmacy. 43(6). 1500–1507. 10 indexed citations
9.
Butković, Ana, et al.. (2021). HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH HAEMOPHILIA AND ITS ASSOCIATION WITH DEPRESSIVE SYMPTOMS: A STUDY IN CROATIA AND SLOVENIA. Psychiatria Danubina. 33(3). 334–341. 3 indexed citations
10.
Vrca, Vesna Bačić, et al.. (2021). Impact of an integrated medication reconciliation model led by a hospital clinical pharmacist on the reduction of post‐discharge unintentional discrepancies. Journal of Clinical Pharmacy and Therapeutics. 46(5). 1326–1333. 9 indexed citations
11.
Vrca, Vesna Bačić, et al.. (2020). Potentially inappropriate medications involved in drug–drug interactions at hospital discharge in Croatia. International Journal of Clinical Pharmacy. 43(3). 566–576. 4 indexed citations
12.
Lucijanić, Marko, et al.. (2018). Pharmacist’s interventions improve time in therapeutic range of elderly rural patients on warfarin therapy: a randomized trial. International Journal of Clinical Pharmacy. 40(5). 1078–1085. 26 indexed citations
13.
Vrca, Vesna Bačić, et al.. (2017). Incidence of statin-drug interactions in Croatian community pharmacy.. PubMed. 72(3). 187–191. 3 indexed citations
14.
Marušić, Srečko, et al.. (2016). Clinical pharmacist-led program on medication reconciliation implementation at hospital admission: experience of a single university hospital in Croatia. Croatian Medical Journal. 57(6). 572–581. 20 indexed citations
15.
Nickerson, Jason, et al.. (2013). Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children. Cochrane Database of Systematic Reviews. 2013(6). CD006602–CD006602. 155 indexed citations
16.
Vrca, Vesna Bačić, et al.. (2012). Antioxidant supplementation and serum lipids in patients with Graves' disease: Effect on LDL-cholesterol. Acta Pharmaceutica. 62(1). 115–122. 12 indexed citations
17.
Škrlin, Jasenka, et al.. (2011). Impact of Ceftriaxone De-restriction on the Occurrence of ESBL-Positive Bacterial Strains and Antibiotic Consumption. Journal of Chemotherapy. 23(6). 341–344. 17 indexed citations
18.
Vrca, Vesna Bačić, et al.. (2009). Consumption of statins in Croatia in the 2002 – 2006 period – a retrospective study. International Journal of Clinical Pharmacology and Therapeutics. 47(7). 469–475.
19.
Barić, Davor, Bojan Biočina, Daniel Unić, et al.. (2007). Topical use of antifibrinolytic agents reduces postoperative bleeding: a double-blind, prospective, randomized study☆. European Journal of Cardio-Thoracic Surgery. 31(3). 366–371. 47 indexed citations
20.
Vrca, Vesna Bačić, et al.. (2004). Supplementation with antioxidants in the treatment of Graves' disease; the effect on glutathione peroxidase activity and concentration of selenium. Clinica Chimica Acta. 341(1-2). 55–63. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026